Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHCY | P23526 | 5/20 | 0.46 |
| ▸ | ADORA2B | P29275 | 4/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 4/20 | 0.45 |
| ▸ | ADORA2A | P29274 | 3/20 | 0.44 |
| ▸ | HSP90B1 | P14625 | 3/20 | 0.44 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.44 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | THRB | P10828 | 1/20 | 0.44 |
| ▸ | BLM | P54132 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL313550 | 0.89 | AHCY (0.60) | AHCYADORA2BADORA3ADORA2AHSP90B1 | |
| SCHEMBL719136 | 0.81 | PRKAB2 (0.61) | ADORA2BADORA3ADORA2AADORA1TSHR | |
| SCHEMBL9052982 | 0.79 | MARS1 (0.56) | ADORA2BADORA3ADORA2AADORA1 | |
| SCHEMBL29387664 | 0.79 | MARS1 (0.56) | ADORA2BADORA3ADORA2AADORA1 | |
| SCHEMBL1120568 | 0.77 | HINT1 (0.59) | — | |
| SCHEMBL28162353 | 0.76 | P2RY1 (0.47) | AHCYADORA2BADORA3ADORA2AHSP90B1 | |
| SCHEMBL31236215 | 0.75 | AHCY (0.50) | AHCYADORA2BADORA3ADORA2AHSP90B1 | |
| SCHEMBL8327426 | 0.75 | ADORA3 (0.70) | AHCYADORA2BADORA3ADORA2AHSP90B1 | |
| SCHEMBL8327434 | 0.75 | ADORA3 (0.70) | AHCYADORA2BADORA3ADORA2AHSP90B1 | |
| SCHEMBL12813018 | 0.74 | DNMT1 (0.57) | AHCYADORA2BADORA3ADORA2AHSP90B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2407474-B1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INST MATERIA MEDICA CAMS (CN) | 2013-08-14 | — | — | EP | claimed |
| US-8435962-B2 | Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat | INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2013-05-07 | — | — | US | claimed |
| US-20120053143-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-03-01 | — | — | US | claimed |
| EP-2407474-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-01-18 | — | — | EP | claimed |
| EP-2407474-B1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INST MATERIA MEDICA CAMS (CN) | 2013-08-14 | — | — | EP | disclosed |
| US-8435962-B2 | Triacetyl-3-hydroxyphenyladenosine and its use for regulating blood fat | INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2013-05-07 | — | — | US | disclosed |
| US-20120053143-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INSTITUTE OF MATARIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-03-01 | — | — | US | disclosed |
| EP-2407474-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF MEDICAL SCIENCES (CN) | 2012-01-18 | — | — | EP | disclosed |
| EP-0191624-A2 | Gold-purine antitumor agents | ENGELHARD CORPORATION (US) | 1986-08-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120053143-A1 | TRIACETYL-3-HYDROXYPHENYLADENOSINE AND ITS USE FOR REGULATING BLOOD FAT | ADORA3, ADORA2A, ADORA1 | AHCY 17/4885ADORA2B 5/4885ADORA3 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.